BioSpace News Archive

Business

The Board of Directors nominates Carlos Gallardo as Vice President of the Board

Almirall, S.A. the global biopharmaceutical company based in Barcelona, has announced the nomination of Carlos Gallardo as Vice President of the Board of Directors effective immediately.

November 9, 2020
·
2 min read
Bio NC

Verona Pharma Announces November 2020 Virtual Investor Conference Participation

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and President, will present a company overview at the following virtual investor conferences in November 2020:

November 9, 2020
·
2 min read
Genetown

Fujirebio Europe and CENTOGENE Enter Partnership to Provide Rapid and High-Quality Preventive SARS-CoV-2 Antigen Testing

Centogene N.V. and Fujirebio Europe announced to have entered a partnership to leverage LUMIPULSE® G technology for large-scale COVID-19 antigen testing with further deployment in German airports.

November 9, 2020
·
9 min read
Business

Dr. Alex Rovira from Hospital Vall d’Hebron joins SyntheticMR’s Medical Advisory Board

SyntheticMR welcomes Dr Alex Rovira to their Medical Advisory Board to support their company with clinical expertise

November 9, 2020
·
1 min read
Drug Development

7 Hills Pharma Announces First Healthy Volunteers Dosed in Landmark Phase 1 Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines

Strengthening immunotherapies is especially critical for older adults with weakened immune systems

November 9, 2020
·
3 min read
Business

Inozyme Pharma Appoints Kevin B. Johnson, Ph.D., MBA, as Senior Vice President, Regulatory Affairs

Dr. Johnson Brings More Than 25 Years of Experience in Developing and Implementing Global Regulatory and Clinical Development Strategies from Preclinical Through Product Approval

November 9, 2020
·
6 min read
Business

Kodiak Sciences Announces Third Quarter 2020 Financial Results and Recent Business Highlights

Kodiak Sciences Inc., a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, reported business highlights and financial results for the third quarter ended September 30, 2020.

November 9, 2020
·
15 min read
Business

Mersana Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update

Presented additional data from XMT-1536 Phase 1 study at ESMO demonstrating compelling and consistent activity and tolerability profile in ovarian cancer

November 9, 2020
·
13 min read
Deals

Decibel Therapeutics Announces $82M Series D Financing to Advance Gene Therapies to Restore Hearing and Balance

Proceeds support advancement of lead gene therapy programs and accelerate development of therapeutics to restore functional hair cells in the inner ear

November 9, 2020
·
3 min read
Biotech Bay

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences - Nov 09, 2020

ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced that Jacob Chacko, M.D., chief executive officer, will participate in the following investor conferences in November:

November 9, 2020
·
2 min read